Search results
Results from the WOW.Com Content Network
Clozapine, sold under the brand name Clozaril among others, is a psychiatric medication and was the first atypical antipsychotic to be discovered. [7] It is used primarily to treat people with schizophrenia and schizoaffective disorder who have had an inadequate response to two other antipsychotics, or who have been unable to tolerate other drugs due to extrapyramidal side effects.
The atypical antipsychotic clozapine has also been suggested as an alternative antipsychotic for patients experiencing tardive dyskinesia. [9] Tardive dyskinesia may reverse upon discontinuation of the offending agent or it may be irreversible, withdrawal may also make tardive dyskinesia more severe.
The atypical antipsychotics (AAP), also known as second generation antipsychotics (SGAs) and serotonin–dopamine antagonists (SDAs), [1] [2] are a group of antipsychotic drugs (antipsychotic drugs in general are also known as tranquilizers and neuroleptics, although the latter is usually reserved for the typical antipsychotics) largely introduced after the 1970s and used to treat psychiatric ...
Depakote (valproic acid/sodium valproate) – an antiepileptic and mood stabilizer used to treat bipolar disorder, neuropathic pain and others; sometimes called an antimanic medication.
The AOL.com video experience serves up the best video content from AOL and around the web, ... Dog Enjoys Windy Snow Day in Ontario. ABC News Videos. Firefighters rescue 6 people, 2 dogs from ...
Weight gain (particularly prominent with clozapine, olanzapine, quetiapine and zotepine, [38] can be counteracted by starting the drug with metformin [125] [126]) Anticholinergic side-effects (common for olanzapine, clozapine; less likely on risperidone [127]) such as: Blurred vision; Constipation; Dry mouth (although hypersalivation may also ...
President John F. Kennedy signs a law dramatically strengthening the FDA; it prohibits drug companies from promoting drugs off-label. Sen. Estes Kefauver (D-Tenn.) champions the bill, warning that without these new restrictions, the “sky would be the limit,” on how companies can market their drugs, and the health of consumers will be in peril.
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee is scheduled to meet on May 24 to review Novo Nordisk A/S’s (NYSE:NVO) application seeking approval for a once-weekly insulin ...